{"id":"https://openalex.org/W2029318860","doi":"https://doi.org/10.1016/0922-4106(91)90105-q","title":"Trifluoperazine inhibits phosphoinositide hydrolysis as a histamine H1-receptor antagonist","display_name":"Trifluoperazine inhibits phosphoinositide hydrolysis as a histamine H1-receptor antagonist","publication_year":1991,"publication_date":"1991-11-01","ids":{"openalex":"https://openalex.org/W2029318860","doi":"https://doi.org/10.1016/0922-4106(91)90105-q","mag":"2029318860","pmid":"https://pubmed.ncbi.nlm.nih.gov/1685127"},"language":"en","primary_location":{"id":"doi:10.1016/0922-4106(91)90105-q","doi":"https://doi.org/10.1016/0922-4106(91)90105-q","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0922-4106(91)90105-q","pdf_url":null,"source":{"id":"https://openalex.org/S4210192051","display_name":"European Journal of Pharmacology Molecular Pharmacology","issn_l":"0922-4106","issn":["0922-4106","1872-8251"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology: Molecular Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109294034","display_name":"Norimichi Nakahata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130830085","display_name":"Fukushima Medical University","ror":"https://ror.org/012eh0r35","country_code":"JP","type":"education","lineage":["https://openalex.org/I130830085"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Norimichi Nakahata","raw_affiliation_strings":["Department of Pharmacology, Fukushima Medical College, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Fukushima Medical College, Japan","institution_ids":["https://openalex.org/I130830085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088963185","display_name":"Hiromi Ishimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130830085","display_name":"Fukushima Medical University","ror":"https://ror.org/012eh0r35","country_code":"JP","type":"education","lineage":["https://openalex.org/I130830085"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiromi Ishimoto","raw_affiliation_strings":["Department of Pharmacology, Fukushima Medical College, Fukushima 960-12, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Fukushima Medical College, Fukushima 960-12, Japan","institution_ids":["https://openalex.org/I130830085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063254714","display_name":"Akiko Takahashi","orcid":"https://orcid.org/0000-0002-6093-7749","observed_orcids":["https://orcid.org/0000-0002-6093-7749"]},"institutions":[{"id":"https://openalex.org/I130830085","display_name":"Fukushima Medical University","ror":"https://ror.org/012eh0r35","country_code":"JP","type":"education","lineage":["https://openalex.org/I130830085"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akiko Takahashi","raw_affiliation_strings":["Department of Pharmacology, Fukushima Medical College, Fukushima 960-12, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Fukushima Medical College, Fukushima 960-12, Japan","institution_ids":["https://openalex.org/I130830085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058264191","display_name":"Kei Ohmori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130830085","display_name":"Fukushima Medical University","ror":"https://ror.org/012eh0r35","country_code":"JP","type":"education","lineage":["https://openalex.org/I130830085"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kei Ohmori","raw_affiliation_strings":["Department of Pharmacology, Fukushima Medical College, Fukushima 960-12, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Fukushima Medical College, Fukushima 960-12, Japan","institution_ids":["https://openalex.org/I130830085"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111723360","display_name":"Masatake Kurita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130830085","display_name":"Fukushima Medical University","ror":"https://ror.org/012eh0r35","country_code":"JP","type":"education","lineage":["https://openalex.org/I130830085"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masatake Kurita","raw_affiliation_strings":["Department of Pharmacology, Fukushima Medical College, Fukushima 960-12, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Fukushima Medical College, Fukushima 960-12, Japan","institution_ids":["https://openalex.org/I130830085"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109294034"],"corresponding_institution_ids":["https://openalex.org/I130830085"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.08131202,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"208","issue":"3","first_page":"265","last_page":"268"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.788100004196167,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.788100004196167,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.17870000004768372,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.02019999921321869,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trifluoperazine","display_name":"trifluoperazine","score":1.0},{"id":"https://openalex.org/keywords/histamine-h1-receptor-antagonism","display_name":"H1 receptor antagonism","score":0.7490000128746033},{"id":"https://openalex.org/keywords/phosphoinositide-hydrolysis","display_name":"phosphoinositide hydrolysis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/astrocytoma-cells","display_name":"astrocytoma cells","score":0.8370000123977661},{"id":"https://openalex.org/keywords/diphenhydramine","display_name":"diphenhydramine","score":0.8799999952316284},{"id":"https://openalex.org/keywords/mepyramine-binding","display_name":"mepyramine binding","score":0.902999997138977},{"id":"https://openalex.org/keywords/quinuclidinyl-benzilate-binding","display_name":"quinuclidinyl benzilate binding","score":0.9810000061988831},{"id":"https://openalex.org/keywords/carbachol","display_name":"carbachol","score":0.7490000128746033},{"id":"https://openalex.org/keywords/receptor-specificity","display_name":"receptor specificity","score":0.3319999873638153}],"concepts":[{"id":"https://openalex.org/C2775891158","wikidata":"https://www.wikidata.org/wiki/Q1752915","display_name":"Trifluoperazine","level":4,"score":0.7848242521286011},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.7019206285476685},{"id":"https://openalex.org/C1122143","wikidata":"https://www.wikidata.org/wiki/Q61233","display_name":"Histamine","level":2,"score":0.6858212351799011},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5782828330993652},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5779876708984375},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.4778139889240265},{"id":"https://openalex.org/C86811712","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Competitive antagonist","level":4,"score":0.41357776522636414},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3237186670303345},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20445680618286133},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19337278604507446},{"id":"https://openalex.org/C29688787","wikidata":"https://www.wikidata.org/wiki/Q409145","display_name":"Calmodulin","level":3,"score":0.14781281352043152},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1334930658340454}],"mesh":[{"descriptor_ui":"D001254","descriptor_name":"Astrocytoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002217","descriptor_name":"Carbachol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004789","descriptor_name":"Enzyme Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006632","descriptor_name":"Histamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006634","descriptor_name":"Histamine H1 Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006868","descriptor_name":"Hydrolysis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010716","descriptor_name":"Phosphatidylinositols","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010738","descriptor_name":"Type C Phospholipases","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010738","descriptor_name":"Type C Phospholipases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011976","descriptor_name":"Receptors, Muscarinic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011976","descriptor_name":"Receptors, Muscarinic","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D014268","descriptor_name":"Trifluoperazine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0922-4106(91)90105-q","doi":"https://doi.org/10.1016/0922-4106(91)90105-q","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0922-4106(91)90105-q","pdf_url":null,"source":{"id":"https://openalex.org/S4210192051","display_name":"European Journal of Pharmacology Molecular Pharmacology","issn_l":"0922-4106","issn":["0922-4106","1872-8251"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology: Molecular Pharmacology","raw_type":"journal-article"},{"id":"pmid:1685127","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1685127","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W132077006","https://openalex.org/W1986226141","https://openalex.org/W2014741603","https://openalex.org/W2025240330","https://openalex.org/W2040326398","https://openalex.org/W2047848482","https://openalex.org/W2067851777","https://openalex.org/W2074631079","https://openalex.org/W2128635872","https://openalex.org/W2438950707","https://openalex.org/W6718439538"],"related_works":["https://openalex.org/W2067851777","https://openalex.org/W2438950707","https://openalex.org/W1972721320","https://openalex.org/W2002314697","https://openalex.org/W1983030082","https://openalex.org/W130020027","https://openalex.org/W1971474866","https://openalex.org/W2029437560","https://openalex.org/W2125542025","https://openalex.org/W2031773005"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}